Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
jtr-161 (1 trial)
Cerebral Infarction (Phase 2)
Ischemia (Phase 2)
Stroke (Phase 2)
Trials (1 total)
Trial APIs (1 total)